These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15161006)

  • 1. Enhancing effect of PS-K on IL-2-induced lymphocyte activation: possible involvement of antagonistic action against TGF-beta.
    Yamaguchi Y; Minami K; Ohshita A; Kawabuchi Y; Noma K; Toge T
    Anticancer Res; 2004; 24(2B):639-47. PubMed ID: 15161006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
    Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW
    J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
    Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ
    Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency.
    Lin SJ; Chao HC; Chang KW; Yan DC
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):65-70. PubMed ID: 12877452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
    Espevik T; Figari IS; Ranges GE; Palladino MA
    J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects.
    Domdey A; Liu A; Millner A; Lund K; Jacobi H; Malling HJ; Søndergaard I; Würtzen PA
    Int Arch Allergy Immunol; 2010; 152(3):243-54. PubMed ID: 20150742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes.
    Cook G; Campbell JD; Carr CE; Boyd KS; Franklin IM
    J Leukoc Biol; 1999 Dec; 66(6):981-8. PubMed ID: 10614781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
    Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro immunomodulatory effects of cuphiin D1 on human mononuclear cells.
    Wang CC; Chen LG; Yang LL
    Anticancer Res; 2002; 22(6C):4233-6. PubMed ID: 12553063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro.
    Kanto T; Takehara T; Katayama K; Ito A; Mochizuki K; Kuzushita N; Tatsumi T; Sasaki Y; Kasahara A; Hayashi N; Hori M
    J Clin Immunol; 1997 Nov; 17(6):462-71. PubMed ID: 9418186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transforming growth factor-beta on early and late activation events in human T cells.
    Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
    J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 inhibits interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells.
    Reinhold D; Bank U; Bühling F; Lendeckel U; Ansorge S
    J Interferon Cytokine Res; 1995 Aug; 15(8):685-90. PubMed ID: 8528940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
    Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
    Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation.
    Jones ML; Young JM; Huang QR; Puls RL; Webber CA; Benson EM
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):283-92. PubMed ID: 12804004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.